0001213900-19-011648.txt : 20190627 0001213900-19-011648.hdr.sgml : 20190627 20190627163057 ACCESSION NUMBER: 0001213900-19-011648 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190627 DATE AS OF CHANGE: 20190627 EFFECTIVENESS DATE: 20190627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-343016 FILM NUMBER: 19925631 BUSINESS ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 D 1 primary_doc.xml X0708 D LIVE 0001553643 RELMADA THERAPEUTICS, INC. 880 THIRD AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10022 212-547-9591 NEVADA Camp Nine, Inc. CAMP NINE, INC. Corporation true Sergio Traversa 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director CEO Charles Casamento 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Chairman of the Board Paul Kelly 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Maged Shenouda 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Ottavio Vitolo 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Chief Medical Officer Biotechnology No Revenues 06b false 2019-06-14 false true true false 10000 Alexander Capital, LP 40077 None None 17 STATE STREET 5TH FLOOR NEW YORK NY NEW YORK 10004 AL ALABAMA AZ ARIZONA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KY KENTUCKY MD MARYLAND MA MASSACHUSETTS MN MINNESOTA NJ NEW JERSEY NY NEW YORK OR OREGON RI RHODE ISLAND SC SOUTH CAROLINA TX TEXAS false Brookline Capital Markets, A division of Arcadia Securities, LLC 44656 None None 509 MADISON AVENUE, SUITE 906 NEW YORK NY NEW YORK 10022 AK ALASKA AZ ARIZONA CO COLORADO GA GEORGIA MD MARYLAND MI MICHIGAN MS MISSISSIPPI NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO TX TEXAS WY WYOMING false 10000000 8002248 1997752 false 108 831370 0 Alexander Capital and Brookline received a cash fee (excluding expenses) of $532,670 and $298,700, respectively, and warrants to purchase an aggregate of 554,242 shares of common stock. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false RELMADA THERAPEUTICS, INC. /s/ Sergio Traversa Sergio Traversa CEO 2019-06-27